The McMackin Lab harnesses MRI and electrophysiological methods, including transcranial magnetic stimulation (TMS), electromyography (EMG) and electroencephalography (EEG), to understand and develop clinically meaningful measures of neurological diseases, including Amyotrophic Lateral Sclerosis (ALS)/Motor Neurone Disease (MND) and Huntington’s disease. The lab also investigates the fundamental human physiology underpinning electrophysiology-based measures, aiming to improve their interpretation and application. In addition, the lab has an interest in understanding sex differences in human physiology and the influence of hormonal fluctuations on physiological processes and neurophysiological measures.
October 2026
PhD student Eva Woods will be attending the European Huntington's Disease Network conference presenting posters K029 and K030 between the 22nd-24th of October. Please visit to find out more about our research in the lab!
September 2026
Eva Woods, PhD student in the lab, delivered a platform presentation at the Brainbox Iniaitive conference about her ongoing work in Huntington's Disease.
August 2026
Our recent study led by McMackin Lab alumnus Séamus O'Sullivan titled "Very low-amplitude muscle activity increases probability of motor evoked potentials in healthy individuals and in amyotrophic lateral sclerosis" was on the cover of Experimental Physiology Volume 111, Issue 8! https://physoc.onlinelibrary.wiley.com/toc/1469445x/2026/111/8